Jane Street’s Pacira BioSciences PCRX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | $3.78M | Sell |
|
|||||
|
2025
Q2 | $3.85M | Sell |
|
|||||
|
2025
Q1 | $8.55M | Buy |
|
|||||
|
2024
Q4 | $1.71M | Buy |
|
|||||
|
2024
Q3 | $333K | Sell |
|
|||||
|
2024
Q2 | $2.32M | Sell |
|
|||||
|
2024
Q1 | $5.48M | Buy |
|
|||||
|
2023
Q4 | $337K | Sell |
|
|||||
|
2023
Q3 | $1.09M | Sell |
|
|||||
|
2023
Q2 | $3.26M | Buy |
|
|||||
|
2023
Q1 | $2.07M | Buy |
|
|||||
|
2022
Q4 | $1.87M | Buy |
|
|||||
|
2022
Q3 | $585K | Sell |
|
|||||
|
2022
Q2 | $1.87M | Buy |
|
|||||
|
2022
Q1 | $1.16M | Sell |
|
|||||
|
2021
Q4 | $1.23M | Buy |
|
|||||
|
2021
Q3 | $504K | Sell |
|
|||||
|
2021
Q2 | $940K | Buy |
|
|||||
|
2021
Q1 | $203K | Sell |
|
|||||
|
2020
Q4 | $379K | Sell |
|
|||||
|
2020
Q3 | $450K | Buy |
|
|||||
|
2020
Q2 | $216K | Buy |
|
|||||
|
2020
Q1 | – | Sell |
|
|||||
|
2019
Q4 | $492K | Buy |
|
|||||
|
2019
Q3 | – | Hold |
|
|||||
|
2019
Q1 | – | Sell |
|
|||||
|
2018
Q4 | $809K | Buy |
|
|||||
|
2018
Q3 | $667K | Buy |
|
|||||
|
2018
Q2 | – | Hold |
|
|||||
|
2018
Q1 | – | Sell |
|
|||||
|
2017
Q4 | $501K | Buy |
|
|||||
|
2017
Q3 | – | Sell |
|
|||||
|
2017
Q2 | $289K | Sell |
|
|||||
|
2017
Q1 | $496K | Sell |
|
|||||
|
2016
Q4 | $617K | Sell |
|
|||||
|
2016
Q3 | $678K | Buy |
|
|||||
|
2016
Q2 | – | Sell |
|
|||||
|
2016
Q1 | $228K | Sell |
|
|||||
|
2015
Q4 | $1.18M | Buy |
|
|||||
|
2015
Q1 | – | Sell |
|
|||||
|
2014
Q4 | $376K | Sell |
|
|||||
|
2014
Q3 | $774K | Sell |
|
|||||
|
2014
Q2 | $1.46M | Buy |
|
|||||
|
2014
Q1 | $360K | Buy |
|